NCT03826316View on ClinicalTrials.gov

Pharmacokinetics of Nalbuphine Injection

PHASE4CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 15, 2018

Primary Completion Date

November 22, 2018

Study Completion Date

January 15, 2019

Conditions
Pain, Postoperative
Interventions
DRUG

Nalbuphine

Pharmacokinetic study under fasting conditions

Trial Locations (1)

Unknown

Taichung Veterans General Hospital, Taichung

All Listed Sponsors
collaborator

Taichung Veterans General Hospital

OTHER

lead

Yung Shin Pharm. Ind. Co., Ltd.

INDUSTRY

NCT03826316 - Pharmacokinetics of Nalbuphine Injection | Biotech Hunter | Biotech Hunter